Analysis of data available on REMBRANDT and TCGA databases revealed that EIF4E1 and EIF4E3 mRNA levels are downregulated whereas EIF4E2 is overexpressed in gliomas (Table 1). This evidence concerns the gene EIF4E3 and central nervous system cancer.